Scholar Rock Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Scholar Rock Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013530
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock LLC is a biotechnology company that discovers and develops biologic therapies. It develops niche activators, modulating supracellular activation, for the application in the treatment of diseases such as fibrosis, diseases of musculoskeletal systems, and autoimmune diseases, using its proprietary technology. Scholar Rock’s proprietary platform enables to create a new class of biologic therapeutics. Its research and development activities concentrate on identifying niche activators. Scholar Rock’s product pipeline focuses in the therapeutic areas of muscle disease, fibrosis, autoimmunity and immuno-oncology. The company’s proprietary technology platform also enables to discover and optimize drug candidates. It collaborates with various biotechnology companies. Scholar Rock is headquartered in Cambridge, Massachusetts, the US.

Scholar Rock Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Scholar Rock Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Scholar Rock Raises USD36 Million in Series B Financing 10
Scholar Rock Raises USD20 Million in Series A Venture Financing 12
Partnerships 13
Scholar Rock Enters Into Research Collaboration With Johnson & Johnson Innovation And Janssen Biotech 13
Licensing Agreements 14
Janssen Biotech Exercises Option for Licensing Agreement with Scholar Rock 14
Scholar Rock Enters into Licensing Agreement with Boston Children’s Hospital 15
Scholar Rock Inc – Key Competitors 16
Scholar Rock Inc – Key Employees 17
Scholar Rock Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Jul 06, 2017: Scholar Rock Appoints David L. Hallal as Chairman of Board of Directors 19
May 23, 2017: Scholar Rock Announces Drug Development Leaders, Michael Gilman and Shelia Violette, to Join Scientific Advisory Board 20
Nov 22, 2016: Scholar Rock Strengthens R&D Leadership with Appointments of New Board Member and Chief Scientific Officer 22
Mar 08, 2016: Scholar Rock Appoints Yung Chyung, MD, as Chief Medical Officer 23
Jan 04, 2016: Scholar Rock Announces Appointment of Leading Fibrosis Expert Dr. Scott L. Friedman to Scientific Advisory Board 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Scholar Rock Inc, Pharmaceuticals & Healthcare, Key Facts 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Scholar Rock Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Scholar Rock Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Scholar Rock Raises USD36 Million in Series B Financing 10
Scholar Rock Raises USD20 Million in Series A Venture Financing 12
Scholar Rock Enters Into Research Collaboration With Johnson & Johnson Innovation And Janssen Biotech 13
Janssen Biotech Exercises Option for Licensing Agreement with Scholar Rock 14
Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 15
Scholar Rock Inc, Key Competitors 16
Scholar Rock Inc, Key Employees 17

★海外企業調査レポート[Scholar Rock Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hikal Ltd (HIKAL):企業の財務・戦略的SWOT分析
    Summary Hikal Ltd (Hikal) is a pharmaceutical company that provides custom manufacturing; active ingredients and intermediates. The company provides product portfolio such as antiepileptic, antihistamine, antipsychotic and antilipemic, among others. It offers services such as custom synthesis, contr …
  • Evraz Plc:企業の戦略・SWOT・財務情報
    Evraz Plc - Strategy, SWOT and Corporate Finance Report Summary Evraz Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • MLP SE (MLP):企業の財務・戦略的SWOT分析
    MLP SE (MLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Valmieras Stikla Skiedra AS:企業の戦略・SWOT・財務情報
    Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report Summary Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • VWR International LLC-医療機器分野:企業M&A・提携分析
    Summary VWR International LLC (VWR), a subsidiary of VWR Corp is a medical device company that offers healthcare equipment. The company’s products comprise adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshener dispensers, air regulation valves, aluminum foil, a …
  • Hewlett Packard Enterprise Company (HPE):企業の財務・戦略的SWOT分析
    Hewlett Packard Enterprise Company (HPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • CaroGen Corp-製薬・医療分野:企業M&A・提携分析
    Summary CaroGen Corp (CaroGen) is a vaccine company that offers platform technology development services. The company develops and commercializes nanoparticle therapeutic vaccines. It utilizes its virus-like vesicle platform technology, a proprietary replication competent to develop nano particle th …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Big Rivers Electric Corporation:企業の発電所・SWOT分析2018
    Big Rivers Electric Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Aker ASA (AKER):石油・ガス:M&Aディール及び事業提携情報
    Summary Aker ASA (Aker) is an industrial investment company that operates through Industrial Holdings and Financial Investments. It invests mainly in energy, environment, fisheries and marine biotech, and finance. Its Industrial Holdings include Aker Solutions ASA, Aker BP, Akastor ASA, Ocean Yield …
  • Mahagenco:企業の戦略的SWOT分析
    Mahagenco - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • OriGene Technologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and sells genome research and diagnostic products. OriGene’s products include qPCR reagents, …
  • Ultrapar Participacoes SA (UGPA3):企業の財務・戦略的SWOT分析
    Ultrapar Participacoes SA (UGPA3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Teledyne Technologies Incorporated (TDY)-石油・ガス分野:企業M&A・提携分析
    Summary Teledyne Technologies Incorporated (Teledyne) is a provider of instrumentation, digital imaging products and software, aerospace and defense electronics and engineered systems. The company provides electronic subsystems, monitoring instrumentation for marine and environmental applications, h …
  • KPMG International:企業の戦略・SWOT・財務分析
    KPMG International - Strategy, SWOT and Corporate Finance Report Summary KPMG International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Otter Tail Corp:企業の発電所・SWOT分析2018
    Otter Tail Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Meiji Yasuda Life Insurance Company:企業の戦略・SWOT・財務情報
    Meiji Yasuda Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Meiji Yasuda Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Crowley Maritime Corp:企業の戦略的SWOT分析
    Crowley Maritime Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CVD Equipment Corp (CVV):企業の財務・戦略的SWOT分析
    Summary CVD Equipment Corp (CVD) is a technology company that manufactures, designs, and develops equipment and process solutions. The company’s product portfolio includes research and development equipments, gas and chemicals systems, production process system, automation equipments, cluster tools, …
  • TaiMed Biologics Inc (4147):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiMed Biologics Inc (TMB) is a biotechnology company that provides novel medicines for the prevention and treatment of viral infectious diseases. The company provides pipeline products such as TMB-355, TMB-607 and TMB-571, among others. It offers TMB-355 which is a proprietary humanized ant …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆